Ruti Alon

General Partner at Pitango. Her investment focus is high-tech medical and Life Sciences startups.

Previously she held senior positions at Montgomery Securities and Kidder Peabody & Co.

established ILSI, Israel Life Science Industry, in 2005, a non-profit organisation representing the mutual goals of approximately 700 Israeli life science companies, now merged with HTIA to form IATI (Israel Advanced Technologies Industries).

Chairperson of the Boards of BioControl and BrainsGate.
Member of the Boards of Apos Therapy, Carbofix Orthopedics and Vascular Biogenics (VBL).

Served on the Boards of ColBar, acquired by Johnson& Johnson, Disc-O-Tech (acquired by Kyphon) and Ventor (acquired by Medtronic (NYSE: MDT)).

Holds a B.A. in Economics from the Hebrew University of Jerusalem, an M.B.A. from Boston University, and an M.S. from the Columbia University School of Physicians and Surgeons.